MarketWatch.com - Top Stories

Ozempic maker Novo Nordisk boots CEO over stock-price fall

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.

May 16, 2025 - 12:50
 0
Ozempic maker Novo Nordisk boots CEO over stock-price fall
Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.
Read More

Tags:

Previous Article

Cava surpasses $1 billion in revenue—CFO says no plans for price increases

Next Article

Dollar Falls on Renewed Speculation Trump Wants to Engineer Weaker Currency

Related Posts

‘Be vigilant with your finances’: My IRA account had an unknown beneficiary listed. How could this happen?

‘Be vigilant with your finances’: My IRA account had an...

May 13, 2025  0

The bull market has survived Trump’s tariff onslaught. But stocks aren’t out of the woods just yet.

The bull market has survived Trump’s tariff onslaught. ...

May 12, 2025  0

The ‘most important consumer earnings report of the season’ lands this week

The ‘most important consumer earnings report of the sea...

May 11, 2025  0